Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes.

PURPOSE: Glycine and serine are well-known, classic metabolites of glycolysis. Here, we profiled the expression of enzymes associated with serine/glycine metabolism in different molecular subtypes of breast cancer and discuss their potential clinical implications. METHODS: We used western blotting a...

Full description

Bibliographic Details
Main Authors: Sang Kyum Kim, Woo Hee Jung, Ja Seung Koo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4076239?pdf=render
_version_ 1819263141815517184
author Sang Kyum Kim
Woo Hee Jung
Ja Seung Koo
author_facet Sang Kyum Kim
Woo Hee Jung
Ja Seung Koo
author_sort Sang Kyum Kim
collection DOAJ
description PURPOSE: Glycine and serine are well-known, classic metabolites of glycolysis. Here, we profiled the expression of enzymes associated with serine/glycine metabolism in different molecular subtypes of breast cancer and discuss their potential clinical implications. METHODS: We used western blotting and immunohistochemistry to examine five serine-/glycine-metabolism-associated proteins (PHGDH, PSAT, PSPH, SHMT, and GLDC) in six breast cancer cell lines and 709 breast cancer cases using tissue microarray (TMA). RESULTS: PHGDH and PSPH, associated with serine metabolism, were highly expressed in the TNBC cells. GLDC, associated with glycine metabolism, was highly expressed in HER-2-positive MDA-MB-453 and TNBC-related MDA-MB-435S. TMA showed that the TNBC-type breast cancer tissues highly expressed PHGDH, PSPH, and SHMT1, but not the luminal-A-type tissues (p<0.001). PSPH and SHMT1 expression in the tumor stroma of HER-2-type cancers was the highest, but the luminal-A tissues showed the lowest expression (p<0.001). GLDC was most frequently expressed in cancer cells and stroma of the HER-2-positive cancers and least frequently in TNBC (p<0.001). By Cox multivariate analysis, tumor PSPH positivity (hazard ratio [HR]: 2.068, 95% confidence interval [CI]: 1.049-4.079, p = 0.036), stromal PSPH positivity (HR: 2.152, 95% CI: 1.107-4.184, p = 0.024), and stromal SHMT1 negativity (HR: 2.142, 95% CI: 1.219-3.764, p = 0.008) were associated with short overall survival. CONCLUSIONS: Expression of serine-metabolism-associated proteins was increased in TNBC and decreased in the luminal-A cancers. Expression of glycine-metabolism-associated proteins was high in the tumor and stroma of HER-2-positive cancers.
first_indexed 2024-12-23T20:08:53Z
format Article
id doaj.art-ec5d9b6c24bf4f998cf3591cc4ead522
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T20:08:53Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ec5d9b6c24bf4f998cf3591cc4ead5222022-12-21T17:32:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e10100410.1371/journal.pone.0101004Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes.Sang Kyum KimWoo Hee JungJa Seung KooPURPOSE: Glycine and serine are well-known, classic metabolites of glycolysis. Here, we profiled the expression of enzymes associated with serine/glycine metabolism in different molecular subtypes of breast cancer and discuss their potential clinical implications. METHODS: We used western blotting and immunohistochemistry to examine five serine-/glycine-metabolism-associated proteins (PHGDH, PSAT, PSPH, SHMT, and GLDC) in six breast cancer cell lines and 709 breast cancer cases using tissue microarray (TMA). RESULTS: PHGDH and PSPH, associated with serine metabolism, were highly expressed in the TNBC cells. GLDC, associated with glycine metabolism, was highly expressed in HER-2-positive MDA-MB-453 and TNBC-related MDA-MB-435S. TMA showed that the TNBC-type breast cancer tissues highly expressed PHGDH, PSPH, and SHMT1, but not the luminal-A-type tissues (p<0.001). PSPH and SHMT1 expression in the tumor stroma of HER-2-type cancers was the highest, but the luminal-A tissues showed the lowest expression (p<0.001). GLDC was most frequently expressed in cancer cells and stroma of the HER-2-positive cancers and least frequently in TNBC (p<0.001). By Cox multivariate analysis, tumor PSPH positivity (hazard ratio [HR]: 2.068, 95% confidence interval [CI]: 1.049-4.079, p = 0.036), stromal PSPH positivity (HR: 2.152, 95% CI: 1.107-4.184, p = 0.024), and stromal SHMT1 negativity (HR: 2.142, 95% CI: 1.219-3.764, p = 0.008) were associated with short overall survival. CONCLUSIONS: Expression of serine-metabolism-associated proteins was increased in TNBC and decreased in the luminal-A cancers. Expression of glycine-metabolism-associated proteins was high in the tumor and stroma of HER-2-positive cancers.http://europepmc.org/articles/PMC4076239?pdf=render
spellingShingle Sang Kyum Kim
Woo Hee Jung
Ja Seung Koo
Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes.
PLoS ONE
title Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes.
title_full Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes.
title_fullStr Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes.
title_full_unstemmed Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes.
title_short Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes.
title_sort differential expression of enzymes associated with serine glycine metabolism in different breast cancer subtypes
url http://europepmc.org/articles/PMC4076239?pdf=render
work_keys_str_mv AT sangkyumkim differentialexpressionofenzymesassociatedwithserineglycinemetabolismindifferentbreastcancersubtypes
AT wooheejung differentialexpressionofenzymesassociatedwithserineglycinemetabolismindifferentbreastcancersubtypes
AT jaseungkoo differentialexpressionofenzymesassociatedwithserineglycinemetabolismindifferentbreastcancersubtypes